Paolo Fundarò
Founder at Xgen Venture Sgr SpA
Profile
Before co-founding XGEN in2021, Paolo was in Genextra since its inception, serving as CEO up to 2022.
Paolo is also board member and co-investor of a number of Genextra companies including Targimmune Therapeutics and Erydel; he is board member and Chairman of Intercept Pharmaceutical (NADAQ: ICPT) since 2006.
Prior to Genextra, he acquired several start-up experiences, including e.Biscom/Fastweb (2000-2004), and investment banking in London.
Paolo is co-founder of Italian Angels for Biotech (IAB).
He holds a cum laude degree in B.A.
& Finance from Bocconi University.
Paolo Fundarò active positions
| Companies | Position | Start |
|---|---|---|
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Director/Board Member | 2012-12-31 |
Applango Systems Ltd.
 Applango Systems Ltd. Packaged SoftwareTechnology Services Applango Systems Ltd. develops software tools for enterprise organizations. It offers Appalango for Adaption which empowers sales managers, tracks usage over time, identifies the frequency of user updates, and pinpoints issues and areas of improvement. The company was founded by Daniel Sarfati in 2012 and is headquartered in Tel Aviv, Israel. | Director/Board Member | 2011-12-31 |
Applango USA, Inc.
 Applango USA, Inc. Packaged SoftwareTechnology Services Applango USA, Inc. develops salesforce applications. It offers Appalango for Adaption which empowers sales managers, tracks usage over time, identifies the frequency of user updates, and pinpoints issues and areas of improvement. The company was founded by Daniel Sarfati in 2012 and is headquartered in Stamford, CT. | Director/Board Member | 2012-12-31 |
InnovHeart Srl
 InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Director/Board Member | 2015-11-30 |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Director/Board Member | 2020-05-31 |
Xgen Venture Sgr SpA
 Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Founder | 2021-05-31 |
Former positions of Paolo Fundarò
| Companies | Position | End |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Chairman | 2023-11-07 |
Genextra SpA
 Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Chief Executive Officer | 2022-06-30 |
| TESSELLIS S.P.A. | Director/Board Member | 2022-05-16 |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Paolo Fundarò
| University of Bocconi | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| TESSELLIS S.P.A. | Communications |
| GENENTA SCIENCE S.P.A. | Health Technology |
| Private companies | 13 |
|---|---|
Credit Suisse (USA), Inc.
 Credit Suisse (USA), Inc. Investment Banks/BrokersFinance Credit Suisse (USA), Inc. provides investment services. It offers securities underwriting and trading, mergers & acquisitions advice, research, private equity investment & derivative, and risk management services. The company was founded in 1959 and is headquartered in New York, NY. | Finance |
Congenia Srl
 Congenia Srl Miscellaneous Commercial ServicesCommercial Services Congenia SRL operates as pharmaceutical company, is engaged in the development of novel therapeutics for diseases associated with mitochondrial stress-induced dysfunction. The company develops small molecule drugs that target the mitochondrial permeability transition pore, a protein channel with various macromolecular components that along with mitochondrial protein p66, appears to be associated with oxidative stress-induced cell death. The company was founded in 2004 by Saverio Minucci, Pier Giuseppe Pelicci, Marco Giorgio and Paolo Bernardi and is headquartered in Milan, Italy. | Commercial Services |
Fastweb SpA
 Fastweb SpA Major TelecommunicationsCommunications Fastweb SpA engages in the provision of solutions for internet connectivity. The firm offers a wide range of voice and data services, fixed communication, and mobile to households and businesses. It also constructs fiber optic network infrastructure and adopts internet protocol for voice, data, and video transmission. The company was founded by Silvio Scaglia in September 1999 and is headquartered in Milan, Italy. | Communications |
| Salomon Smith Barney International Ltd. | Finance |
Genextra SpA
Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Finance |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Health Technology |
Applango USA, Inc.
Applango USA, Inc. Packaged SoftwareTechnology Services Applango USA, Inc. develops salesforce applications. It offers Appalango for Adaption which empowers sales managers, tracks usage over time, identifies the frequency of user updates, and pinpoints issues and areas of improvement. The company was founded by Daniel Sarfati in 2012 and is headquartered in Stamford, CT. | Technology Services |
Applango Systems Ltd.
Applango Systems Ltd. Packaged SoftwareTechnology Services Applango Systems Ltd. develops software tools for enterprise organizations. It offers Appalango for Adaption which empowers sales managers, tracks usage over time, identifies the frequency of user updates, and pinpoints issues and areas of improvement. The company was founded by Daniel Sarfati in 2012 and is headquartered in Tel Aviv, Israel. | Technology Services |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
Dac SRL
 Dac SRL Motor VehiclesConsumer Durables Dac SRL is an Italian company that manufactures and sells car, bike, motorbike accessories, and spare parts. The private company is based in Cavriago, Italy. | Consumer Durables |
InnovHeart Srl
InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Health Technology |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Finance |
- Stock Market
- Insiders
- Paolo Fundarò
